World Journal of Dentistry

Register      Login

VOLUME 8 , ISSUE 2 ( March-April, 2017 ) > List of Articles

RESEARCH ARTICLE

Assessment and Comparison of Salivary Survivin Biomarker in Oral Leukoplakia, Oral Lichen Planus, and Oral Cancer: A Comparative Study

Ruchika Garg, Arvind V Shetti, Anjana S Bagewadi

Citation Information : Garg R, Shetti AV, Bagewadi AS. Assessment and Comparison of Salivary Survivin Biomarker in Oral Leukoplakia, Oral Lichen Planus, and Oral Cancer: A Comparative Study. World J Dent 2017; 8 (2):73-76.

DOI: 10.5005/jp-journals-10015-1415

Published Online: 00-04-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction

Oral squamous cell carcinoma (OSCC) is the most common malignant tumor of the oral cavity. It is preceded by various potentially malignant conditions like oral leukoplakia and oral lichen planus. Survivin is an inhibitor of apoptosis whose levels have been found increased in oral cancer as well as various potentially malignant conditions. Thus survivin can act as a biomarker and help in early detection of potentially malignant conditions which can prevent its transformation into malignancy.

Aim

To assess and compare the level of total human salivary survivin in oral leukoplakia, oral lichen planus, oral cancer, and control group.

Materials and methods

A total of 96 subjects were included in the study, which were further grouped into 24 in each group. The saliva was analyzed for survivin level among all the four groups. Survivin concentration (pg/mL) was studied in relation to clinical data.

The results were analyzed using Mann—Whitney U test to derive the statistical difference.

Results

The average of levels of survivin in control group was 0.199 pg/mL, in oral leukoplakia group 0.312 pg/mL, in oral lichen planus group 0.380 pg/mL, and in oral cancer group 0.430 pg/mL. A comparison of all these groups revealed statistically significant difference among the groups.

Conclusion

Survivin may not be considered as an independent predictor of the malignant transformation for premalignant lesions but it can be an indicator for an increased risk of malignant transformation.

How to cite this article

Garg R, Shetti AV, Bagewadi AS. Assessment and Comparison of Salivary Survivin Biomarker in Oral Leukoplakia, Oral Lichen Planus, and Oral Cancer: A Comparative Study. World J Dent 2017;8(2):73-76.


PDF Share
  1. An indirubin derivative, indirubin-3-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin. PLoS One 2013 Aug;8(8):e70198.
  2. Detection level of salivary survivin in patients with OSCC. J Carcinogene Mutagene 2013 Oct. doi:10.4172/2157-2518.S5-004.
  3. Biochemical markers in saliva of patients with oral squamous cell carcinoma. Asian Pac J Trop Dis 2014 Dec;4(Suppl 1):S33-S40.
  4. Expression of survivin and caspase 3 in oral squamous cell carcinoma and peritumoral tissue. Asian Pac J Cancer Prev 2012;13(10):5027-5031.
  5. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings. Head Neck 2009 Aug;31(8):1039-1048.
  6. Cytoplasmic expression of survivin is an independent predictor of poor prognosis in patients with salivary gland cancer. Histopathology 2010 Nov;57(5):699-706.
  7. Apoptosis and autoimmune diseases. IUBMB Life 2006 May-Jun;58(5-6):358-362.
  8. Apoptosis in the pathogenesis and treatment of disease. Science 1995 Mar;267(5203):1456-1462.
  9. cation of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007 Nov;36(10):575-580.
  10. Oral lichen planus -a clinical evaluation of 115 cases. J Oral Surg Oral Med Oral Pathol 1968 Jan;25(1):31-42.
  11. Proposal for modification of the TNM staging classification for cancer of the oral cavity. J Craniomaxillofac Surg 1999 Oct;27(5):275-288.
  12. Lactate dehydrogenase: an enzymatic biomarker in oral health and disease. Int J Contemp Dent Med Rev 2015 Sep; 2015:040815.
  13. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008 Oct;14(19):6246-6252.
  14. Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol 2004 Feb;171(2 Pt 1):626-630.
  15. Expression of an inhibitor of apoptosis, survivin in oral carcinogenesis. J Dent Res 2003 Aug;82(8):607-611.
  16. Expression of survivin in oral squamous cell carcinoma. Oral Med Pathol 2006;11(2):41-44.
  17. Survivin expression in oral squamous cell carcinoma. Br J Cancer 2003 Dec;89(12):2244-2248.
  18. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010 Oct;110(4):484-491.
  19. Diagnostic aids in detection of oral precancer and cancer: past to present. Int Dent Med J Adv Res 2016;2:1-7.
  20. Saliva: a mirror to health. Int J Contemp Dent Med Rev 2015;2015:030715
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.